Qualitative analysis of cancer patients' experiences using donated human milk

Journal of Human Lactation

Volumn 25, Issue 2, 2009, Pages 211-219

  Rough, Susanne M ^a   Sakamoto, Pauline ^b   Fee, Caroline H ^c   Hollenbeck, Clarie B ^c  

^a KAISER PERMANENTE   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c SAN JOSE STATE UNIVERSITY   (United States)

Author keywords

Cancer; Donor milk banking; Human milk; Quality of life; Research

Indexed keywords

ADULT; AGED; ARTICLE; BREAST MILK; CANCER PATIENT; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DONOR SELECTION; FEMALE; HUMAN; MALE; MOTIVATION; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SAMPLING; STRUCTURED INTERVIEW;

ADULT; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MILK, HUMAN; NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 65549109326     PISSN: 08903344     EISSN: 15525732     Source Type: Journal    
DOI: 10.1177/0890334409333422     Document Type: Article

References (17)

1. Hakansson A., Zhivotovsky B., Orrenius S., Sabharwal H., Svanborg C. Apoptosis induced by a human milk protein. Proc Natl Acad Sci U S A. 1995;92:8064-8068.
2. Fischer W., Gustafsson L., Mossberg AK, et al. Human alpha-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survival. Cancer Res. 2004;64:2105-2112.
3. Gustafsson L., Leijonhufvud I., Aronsson A., Mossberg AK, Svanborg C. Treatment of skin papillomas with topical alpha-lactalbumin-oleic acid. N Engl J Med. 2004;350:2663-2672.
4. Caspi O., Koithan M., Criddle M. Alternative medicine or "alternative" patients: A qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine. Med Decis Making. 2004;24:64-79.
5. Litwin M., Fitzpatrick JM, Fossa S., Newling DWW. Defining an international research agenda for quality of life in men with prostate cancer. Prostate. 1999;41:58-67.
6. Lindley C. Quality of life measurements in oncology. Pharmocotherapy. 1992;12:346-352.
7. Svensson M., Duringer C., Hallgren O., Mossberg AK, Hakansson A., Svanborg C. HAMLET-a complex from human milk that induces apoptosis in tumor cells but spares healthy cells. Adv Exp Med Biol. 2002;503:125-132.
8. Schapira MM, Lawrence WF, Katz DA, McAuliffe TL, Nattinger AB Effect of treatment on quality of life among men with clinically localized prostate cancer. Med Care. 2001;39:243-253.
9. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004;9:80- 89.
10. Verhoef MJ, Hilsden RJ, O'Beirne M. Complementary therapies and cancer care: An overview. Patient Educ Couns. 1999;38:93-100.
11. Spence M., Ribeaux P. Complementary and alternative medicine: Consumers in search of wellness or an expression of need by the sick ? Psychology and Marketing. 2004;21:113-139.
12. Boon H., Stewart M., Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol. 2000;18:2515-2521.
13. Human Milk Bank Association of North America. Guidelines for the Establishment and Operation of a Donor Human Milk Bank. Raleigh, NC: HMBANA; 2005: 24.
14. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA. 1998;280:1569-1575.
15. Harris P., Finlay I., Cook A., Thomas KJ, Hood K. Complementary and alternative medicine use by patients with cancer in Wales: A cross sectional survey. Complement Ther Med. 2003;11:249-253.
16. Barrett B. Complementary and alternative medicine: What's it all about ? Wis Med J. 2001;100:20-26.
17. Tang ST, McCorkle R. Use of family proxies in quality of life research for cancer patients at the end of life: A literature review. Cancer Invest. 2002;20:1086-1104.